Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07596199Phase 3Active, not recruiting
A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Jun 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07596199.